Next Generation Leadership: Building Multi-Generational Success While Pursuing New Platforms

While pursuing major initiatives like the Mixon partnership, Waud Capital Partners’ recent promotions signal multi-generational strength. The January 2025 elevation of Tim Cremieux, Kyle Lattner, and Paul Sutphin to Partner, along with Mike Lehman’s promotion to Principal, demonstrates systematic succession planning that ensures continuity beyond any single leader.

Reeve Waud addressed the importance of talent development: “At Waud Capital, we firmly believe that exceptional people drive exceptional value, and it holds true in both our portfolio and firm. I am proud of the caliber of talent we have within Waud Capital, and these promotions are a testament to that.”

Developing Leaders Through Complex Transactions

Kyle Lattner’s journey exemplifies the firm’s approach to leadership development. Joining Waud Capital in 2013, he has spent over a decade building expertise across healthcare services investments. His involvement in the recent Senior Helpers and Mopec Group acquisitions, combined with long-term support of portfolio companies like Ivy Rehab, demonstrates deep sector knowledge developed through hands-on experience.

Lattner’s role in the Mixon partnership showcases this evolution. As he explained: “The partnership with Bill is another example of Waud Capital’s executive-first campaign approach and commitment to support accomplished executive leaders with the full ecosystem of resources to execute transformative growth strategies in large, growing markets.”. His ability to articulate strategy while executing complex transactions reflects readiness for expanded leadership responsibilities.

Mike Lehman’s promotion to Principal recognizes his contributions since joining in 2021. His work supporting Ivy Rehab and Unifeye Vision Partners, combined with involvement in the Mopec Group acquisition, demonstrates rapid development of healthcare expertise. His perspective on the Mixon opportunity – “He is an exceptional executive who has created value and driven multiple successful outcomes throughout his career in a sector we find highly attractive” – shows sophisticated understanding of executive assessment and sector dynamics.

Family Legacy and Fresh Perspectives

The presence of Reeve Waud Jr. on the healthcare investment team adds another dimension to succession planning. Working closely with portfolio companies including Concierge Home Care, PromptCare, and AltoCare, he brings fresh perspectives while learning from decades of institutional knowledge. His involvement spans the entire deal process from origination through post-investment management, ensuring comprehensive understanding of the firm’s approach.

This combination of family continuity and merit-based advancement creates cultural stability while avoiding stagnation. Chris Graber, Partner and Head of the Healthcare Group, noted: “All of these new Partners have demonstrated extraordinary leadership, delivering value, insights and expertise to their portfolio companies and contributing to the continued success of Waud Capital.”

Institutional Knowledge Transfer

With over 500 completed investments, Waud Capital Partners possesses deep institutional knowledge requiring systematic transfer to rising leaders. The firm’s ecosystem approach facilitates this knowledge transfer through structured processes, documented best practices, and collaborative deal teams combining senior and junior professionals.

Tim Cremieux’s elevation to Partner after helping lead the PharmAlliance platform investment demonstrates successful knowledge transfer. Joining in 2017, he has developed expertise across pharma services, payor services, and medication supply chain sectors. His support of current portfolio companies Apotheco, PromptCare, and Provider Network Holdings shows ability to manage multiple complex investments simultaneously.

Paul Sutphin’s progression offers another success story. Joining Waud Capital in 2013, he helped lead the Science Exchange investment while supporting portfolio companies across software and healthcare IT sectors. His decade-long tenure provided exposure to numerous transactions, exit processes, and market cycles – experience essential for partnership responsibilities.

Continuity Planning Across Investment Cycles

The healthcare supply chain partnership with Bill Mixon demonstrates how leadership development enables pursuit of ambitious new platforms while maintaining existing portfolio excellence. Capital deployment exceeding $100 million demands senior attention while current investments require continued support.

Justin DuPere, Partner and Co-Head of the Software & Technology Group, connected promotions to future ambitions: “These promotions underscore our momentum going into 2025 as we look to deploy capital across key sectors. Our newly elevated leaders exemplify our talent-led, thesis-driven investment approach that will help us successfully capitalize on opportunities in the year to come.”

Building Sustainable Excellence

The systematic development of next-generation leadership ensures Waud Capital’s healthcare investment excellence extends beyond founding partners. This sustainability proves crucial as the firm manages increasingly complex portfolios across multiple funds and sectors. The ability to pursue new opportunities like the Mixon partnership while supporting existing investments requires deep bench strength.

Reeve Waud’s approach to succession combines patience with urgency – developing leaders over years while recognizing promotion readiness. The January 2025 promotions, coming as the firm pursues major new investments, demonstrate confidence in the next generation’s ability to drive continued success.

Through careful cultivation of emerging leaders, systematic knowledge transfer, and strategic succession planning, Reeve Waud ensures the investment excellence he has built over three decades will continue for generations. The Mixon partnership represents not just another successful platform but validation that Waud Capital Partners has developed the institutional capabilities and leadership depth necessary for sustained excellence in healthcare investing.

Related: Ivy Rehab Announces CEO Transition: Jason Strauss to Succeed Michael Rucker as Chief Executive Officer